Other News

Centers Commence Enrollment in KNOCOUT PE Study to Measure the Impact of Shorter, Even Safer EKOS® Therapy Protocols for Pulmonary Embolism

BOTHELL, Wash.–(BUSINESS WIRE)–BTG plc (LSE: BTG), the global specialist healthcare company, today highlights the commencement of the KNOCOUT PE study. The KNOCOUT PE study will measure how hospitals and patients are benefitting from a new standard of care in the treatment of Pulmonary Embolism utilizing EKOS® therapy with faster, and even […]

Saranas Named Finalist for Prestigious International Cardiovascular Innovation Award

HOUSTON–(BUSINESS WIRE)–Saranas, a medical device company with a new technology for real-time detection and monitoring of internal bleeding during endovascular procedures, today announced the company was named as one of the Top 4 Innovators at the International Conference for Innovations in Cardiovascular Systems (ICI) in Tel Aviv, Israel. The ICI […]

Bay Area’s Bay Labs Completes $5.5M Series A Funding Round

SAN FRANCISCO–(BUSINESS WIRE)– Bay Labs, a medical technology company at the forefront of applying artificial intelligence (AI) to cardiovascular imaging, today announced it completed $5.5 million in financing. The Series A round was led by existing investor Khosla Ventureswith participation from new investors including Data Collective (DCVC), Greenbox Venture Partners, Minneapolis Heart Institute Ventures and Georges Harik. […]

Cibiem Appoints William H. Kucheman to the Board of Directors

LOS ALTOS, Calif.–(BUSINESS WIRE)– Cibiem, a clinical-stage medical device company targeting the carotid body to treat diseases like hypertension and heart failure, today announced that industry veteran William H. (Hank) Kucheman has joined its board of directors. Mr. Kucheman’s addition expands Cibiem’s number of directors to seven as he joins independent […]

HeartFlow Announces Decision by HCSC and Additional BlueCross BlueShield Companies to Issue New Positive Medical Policies for Non-Invasive HeartFlow FFRct Analysis

REDWOOD CITY, Calif.–(BUSINESS WIRE)– HeartFlow today announced that Health Care Service Corporation (HCSC), which operates Blue Cross and Blue Shield plans in Illinois, Montana, New Mexico, Oklahoma and Texas, has issued a medical policy for the HeartFlow® FFRct Analysis, a first-of-its-kind non-invasive technology that helps clinicians diagnose and treat patients with suspected coronary artery disease (CAD). HCSC […]

Velano Vascular Named to 2017 FierceMedTech’s “Fierce 15”

SAN FRANCISCO, Dec. 12, 2017 (GLOBE NEWSWIRE) — Velano Vasculartoday announced that it was named by FierceMedTech as one of 2017’s Fierce 15 med tech companies, acknowledging the company as one of the most promising private companies in the industry for its breakthrough work addressing the world’s growing vascular access challenges. More than one […]

PQ Bypass Receives IDE Approval to Initiate Study of First-of-its-Kind Procedure for Patients Suffering From Peripheral Artery Disease

SUNNYVALE, Calif.–(BUSINESS WIRE)–PQ Bypass, Inc., today announced it has received conditional approval of its investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) to initiate the pivotal DETOUR II clinical trial. As the first-ever pivotal trial for percutaneous femoropopliteal bypass, DETOUR II will evaluate the safety and […]

FierceMedTech Names Endotronix as one of its “Fierce 15” MedTech Companies of 2017

LISLE, Ill., Dec. 11, 2017 /PRNewswire/ — Endotronix, Inc., a digital health medtech company providing innovative solutions for heart failure management, today announced that it has been named by FierceMedTech as one of 2017’s Fierce 15 MedTech companies, recognizing it as one of the most promising private medical technology companies in the industry. “We are honored […]